Samedan Ltd Pharmaceutical Publishers


Advanced search

Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online Conferences White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

home > ict

PUBLICATIONS

International Clinical Trials

International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.

Published quarterly, the journal offers a platform of communication and information-sharing for executive and strategic decision makers, seeking out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. ICT is specifically designed to be of interest to those actively seeking to source services for improved efficiency in what is an increasingly competitive market.

Prompted by the synergies between trial operations and wider contract research and outsourcing issues, ICT joined forces with sister title European Pharmaceutical Contractor (EPC) in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.

For further information please contact:
Advertising Simon Caplan	Editorial Caitlin O'Sullivan

Connect with us on Twitter: follow @IntClinTrials

	Click here to view the digital version of ICT
	Click here to view the digital version of EPC

	Subscribe
	Current Issue
	Archives
	Media Info
	Our Clients

Featured in this issue

eClinical Trends

Embracing the Future of Hybrid Trials

Fred Martin at Medrio

In the resulting digital boom resulting from the global pandemic, trials have become more virtual. However, a one-size-fits-all approach isn’t always the solution, and many researchers are opting for a design incorporating the best of both worlds

EPC

What Is Leadership in a COVID-19 Era?

Claire Pegg, Trust Lead Research Nurse, and Ross Downes at the NIHR

Two leaders from the NHS and National Institute of Health Research (NIHR), Claire Pegg and Ross Downes (overleaf), share their insights into what this pandemic has meant for their teams, their styles of management, and what could be in store for mentors in the future

Therapeutic Focus: Neurology

Personalised Medicine for Psychiatry Requires Novel Trial Designs

Dr Hans Eriksson at HMNC Brain Health

Neuropsychiatric disorders are some of the most complex in healthcare, especially when it comes to depression. Designing a trial for these vulnerable patients involves careful and complex protocols

Published quarterly in
February, May,
August, and November

News and Press Releases

Reify Health Raises $220 Million to Eliminate Waiting in Clinical Trials

Reify Health today announced a $220 million Series C funding round led by Coatue Management, joined by ICONIQ Growth and Adams Street Partners, as well as existing investors Sierra Ventures and Battery Ventures.
More info >>

All releases >>

White Papers

Tightening Your Supply Chain Against Counterfeits

World Courier

As today’s global pharmaceutical supply chain grows increasingly longer and more complex, each link provides added opportunity for counterfeiters. While pending regulatory changes promise to tighten the supply chain with respect to production and distribution entities and new packaging technologies will make the identification of counterfeit products easier, the logistics of global distribution remains a weak link. How can the pharmaceutical shipper ensure the security of the supply chain over thousands of miles and extended periods of time when the product is no longer in his possession?
More info >>

All white papers >>